Catalyst Funds Management Pty »

Amneal Pharmaceuticals shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-09-30 $169k 17k 10.01
2025-06-30 $313k 39k 8.09
2024-03-31 $63k 10k 6.06

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Rubric Capital Management
Tpg Gp A
Citadel Advisors
Dimensional Fund Advisors
Nantahala Capital Management
Geode Capital Management
State Street Corporation
Neuberger Berman Group
Millennium Management
Nuveen
Acadian Asset Management
Morgan Stanley
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals